Audio is streamed directly from the publisher (track.fstry.me) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
高風險性早期三陰性乳癌過去僅有化療選項，如今健保首度納入PARP抑制劑與免疫藥物輔助治療，為近20年來首次重大突破，象徵台灣乳癌治療正式接軌國際。今天就來和高雄市乳癌防治衛教學會侯明鋒理事長聊一聊這個議題。
Topics
三陰性乳癌乳癌化療免疫療法